Clinical Trial Update: A Study for Patients With Secondary Progressive Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a study in Secondary Progressive Multiple Sclerosis that enrolled patients in Phase 2 and Phase 3 and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED